Literature DB >> 7702055

Plasma renin activity in hemodialyzed patients during long-term follow-up.

G Kimura1, N Takahashi, Y Kawano, T Inenaga, T Inoue, S Nakamura, T Inoue, H Matsuoka, T Omae.   

Abstract

Plasma renin activity (PRA) and mean arterial pressure (MAP) were determined in 11 patients after the initiation of maintenance hemodialysis for 8 to 10 years. PRA increased significantly from 2.3 +/- 0.5 to 6.5 +/- 1.3 ng/mL/h, whereas MAP was lowered during follow-up, and there was a strong correlation between these two (r = 0.88, P < 0.001). Immediately before initiating hemodialysis, PRA was negatively correlated with the increase in PRA (r = 0.62, P < 0.05) and positively correlated with the reduction in MAP (r = 0.65, P < 0.05). PRA was elevated and MAP was markedly reduced in patients whose PRA was relatively low immediately before initiating hemodialysis, whereas PRA tended to be reduced and MAP was unchanged in patients with higher levels of PRA. These data suggest that renin secretion continues even after disuse atrophy of the kidneys with almost complete deterioration of its excretory function.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7702055     DOI: 10.1016/0272-6386(95)90128-0

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  5 in total

1.  The association of plasma prorenin level with an oxidative stress marker, 8-OHdG, in nondiabetic hemodialysis patients.

Authors:  Yoshiyuki Morishita; Shiho Hanawa; Takuya Miki; Taro Sugase; Yasuhiro Sugaya; Junko Chinda; Osamu Iimura; Sadao Tsunematsu; Kenichi Ishibashi; Eiji Kusano
Journal:  Clin Exp Nephrol       Date:  2011-01-15       Impact factor: 2.801

2.  Intrarenal renin-angiotensin system activity is augmented after initiation of dialysis.

Authors:  Naro Ohashi; Shinsuke Isobe; Sayaka Ishigaki; Takahisa Suzuki; Masafumi Ono; Tomoyuki Fujikura; Takayuki Tsuji; Akihiko Kato; Seiichiro Ozono; Hideo Yasuda
Journal:  Hypertens Res       Date:  2016-10-20       Impact factor: 3.872

3.  Efficacy of Losartan in the management of Post-Dialysis Euvolemic Hypertension (HELD-Trial): A Single-Blind Randomized Control Trial.

Authors:  Raja Ahsan Aftab; Amer Hayat Khan; Azreen Syazril Adnan; Syed Azhar Syed Sulaiman; Tahir Mehmood Khan
Journal:  Sci Rep       Date:  2016-12-06       Impact factor: 4.379

4.  Protocol of randomized control trial for effectiveness of angiotensin receptor blockers on blood pressure control among euvolemic hypertensive hemodialysis patients.

Authors:  Raja Ahsan Aftab; Amer Hayat Khan; Syed Azhar Syed Sulaiman; Tahir Mehmood Khan; Azreen Syazril Adnan
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

5.  A Real Saline Challenge: Diagnosing Primary Aldosteronism in the Setting of Chronic Kidney Disease.

Authors:  Sasan Mirfakhraee; Maria Rodriguez; Niloofar Ganji; Richard J Auchus; Oksana Hamidi
Journal:  J Investig Med High Impact Case Rep       Date:  2021 Jan-Dec
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.